Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T, Suzuki K, Masunaga Y, Taguchi K, Morihira K, Sato I, Fujii M, Takizawa S, Torii Y, Yamamoto N, Kaneko M, Yamada T, Takahashi K, Shimizu Y. Morokata T, et al. J Pharmacol Exp Ther. 2006 Apr;317(1):244-50. doi: 10.1124/jpet.105.097048. Epub 2005 Dec 9. J Pharmacol Exp Ther. 2006. PMID: 16339911
In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031.
Suzuki K, Morokata T, Morihira K, Sato I, Takizawa S, Kaneko M, Takahashi K, Shimizu Y. Suzuki K, et al. Among authors: morokata t. Biochem Biophys Res Commun. 2006 Jan 27;339(4):1217-23. doi: 10.1016/j.bbrc.2005.11.141. Epub 2005 Dec 5. Biochem Biophys Res Commun. 2006. PMID: 16343433
A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
Suzuki K, Morokata T, Morihira K, Sato I, Takizawa S, Kaneko M, Takahashi K, Shimizu Y. Suzuki K, et al. Among authors: morokata t. Eur J Pharmacol. 2007 Jun 1;563(1-3):224-32. doi: 10.1016/j.ejphar.2007.01.074. Epub 2007 Feb 8. Eur J Pharmacol. 2007. PMID: 17336292
Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists.
Sato I, Morihira K, Inami H, Kubota H, Morokata T, Suzuki K, Hamada N, Iura Y, Nitta A, Imaoka T, Takahashi T, Takeuchi M, Ohta M, Tsukamoto S. Sato I, et al. Among authors: morokata t. Bioorg Med Chem. 2008 Jan 1;16(1):144-56. doi: 10.1016/j.bmc.2007.10.003. Epub 2007 Oct 5. Bioorg Med Chem. 2008. PMID: 17951061
Pyrrolidinyl phenylurea derivatives as novel CCR3 antagonists.
Nitta A, Iura Y, Inoue H, Sato I, Morihira K, Kubota H, Morokata T, Takeuchi M, Ohta M, Tsukamoto S, Imaoka T, Takahashi T. Nitta A, et al. Among authors: morokata t. Bioorg Med Chem Lett. 2012 Nov 15;22(22):6876-81. doi: 10.1016/j.bmcl.2012.09.035. Epub 2012 Sep 20. Bioorg Med Chem Lett. 2012. PMID: 23046963
46 results